​Ovarian

• (149-17) Phase II, Double-Blind, Randomized Trial Of AVOVA-1 (Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens) Vs. Autologous Peripheral Blood Mononuclear Cells (MC) In Patients With Stage III Or IV Epithelial Ovarian, Fallopian Tube Or Primary Peritoneal Carcinoma After Primary Therapy (Phase 2 clinical trial, appropriate for patients with ovarian cancer.)

• (157-17) FID-007 in Treating Participants With Advanced Solid Tumors (Phase 1 clinical trial, appropriate for patients with advanced solid malignancies.)

• (167-17) Caris ctDNA Validation Project (Research study, appropriate for patients with all solid tumors.)

• (179-17) Pilot program to assess the potential role of pharmacogenomics to improve drug safety in patients with advanced cancer. (Clinical research study, appropriate for patients with brain, breast, GI, lung or ovarian cancer.)

• (187-17) Phase 1 trial of ZW25 in patients with locally advanced (unresectable) and/or metastatic HER2-expressing cancers (Phase 1 clinical trial, appropriate for patients with HER2 expressing cancers.)

• (211-17) Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients (Phase 1 clinical trial, appropriate for patients with advanced solid tumors.)

Certain clinical trials may not be listed on ClinicalTrials.gov. To learn more about these or other clinical trials, please call 949-764-5543 or contact us online.